China VenturesChina Ventures 中华创投协会DEAL MARKETPLACE
Health & Bio · Beta

Helix Foundry

Cell-therapy manufacturing for China's biotechs.

BetaListings are in beta: details come from the parties and are not independently verified. Read the disclaimer.
Raising$18m
StageSeries B
RegionChina
Valuation$95m
Traction14 biotech clients · ¥60m revenue
The business

What it does

Helix Foundry is a CDMO for CAR-T and NK cell therapies, offering vector production and fill-finish under one quality system. Fourteen biotech clients are under contract and a second suite is coming online.

Members only

Login to see details

Sign in to see the summary, the evidence and use of funds for Helix Foundry. Membership is free.

We never publish contact details on the site. After approval the system will make an intelligent match.